Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

LH846

Copy Product Info
🥰Excellent
Catalog No. T1877Cas No. 639052-78-1
Alias LH-846, LH 846

LH846 is a selective inhibitor of CK1δ with IC50 values of 290 nM for CK1δ, 1.3 μM for CK1ε, and 2.5 μM for CK1α, and exhibits no inhibitory activity at CK2.

LH846

LH846

Copy Product Info
🥰Excellent
Purity: 98.26%
Catalog No. T1877Alias LH-846, LH 846Cas No. 639052-78-1
LH846 is a selective inhibitor of CK1δ with IC50 values of 290 nM for CK1δ, 1.3 μM for CK1ε, and 2.5 μM for CK1α, and exhibits no inhibitory activity at CK2.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$58In StockIn Stock
10 mg$79In StockIn Stock
25 mg$148In StockIn Stock
50 mg$247In StockIn Stock
1 mL x 10 mM (in DMSO)$58In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.26%
Appearance:Solid
Color:White to Purple
Contact us for more batch information

Resource Download

Product Introduction

LH846 AI Summary
LH846 displays antiviral activity by inhibiting the cytotoxic effects of SARS-CoV-2 in Caco-2 and VERO-6 cells, showing an inhibition rate of 4.44% and -0.15% respectively at a concentration of 10 µM after 48 hours as determined by high-content imaging. Additionally, it inhibits the SARS-CoV-2 3CL-Pro protease by 13.59% at 20 µM as detected through FRET response from a peptide substrate. Furthermore, LH846 demonstrates potential as a human HDAC6 enzyme inhibitor, with inhibitions of 19.68% and 1.03% using commercial and custom peptide substrates in enzymatic assays..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
LH846 is a selective inhibitor of CK1δ with IC50 values of 290 nM for CK1δ, 1.3 μM for CK1ε, and 2.5 μM for CK1α, and exhibits no inhibitory activity at CK2.
Targets&IC50
CK1ε:1.3 μM, CK1α:2.5 μM, CK1δ:290 nM
SynonymsLH-846, LH 846
Chemical Properties
Molecular Weight316.81
FormulaC16H13ClN2OS
Cas No.639052-78-1
SmilesCc1cc2sc(NC(=O)Cc3ccccc3)nc2cc1Cl
Relative Density.1.387 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 55 mg/mL (173.61 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+90% Corn Oil: 2.5 mg/mL (7.89 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.1565 mL15.7823 mL31.5647 mL157.8233 mL
5 mM0.6313 mL3.1565 mL6.3129 mL31.5647 mL
10 mM0.3156 mL1.5782 mL3.1565 mL15.7823 mL
20 mM0.1578 mL0.7891 mL1.5782 mL7.8912 mL
50 mM0.0631 mL0.3156 mL0.6313 mL3.1565 mL
100 mM0.0316 mL0.1578 mL0.3156 mL1.5782 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy LH846 | purchase LH846 | LH846 cost | order LH846 | LH846 chemical structure | LH846 formula | LH846 molecular weight